On Wednesday, in a statement, CStone Pharmaceuticals stated, a unit of Pfizer Inc has agreed to acquire a 9.9% stake in it for $200 million (HK$1.55 billion). With the news reaching the market the shares of the Hong Kong-listed biopharmaceutical… Read More ›